Non-vascular Abdominal Disease: Diagnosis and Therapy

  • Carlo Bartolozzi
  • Valentina Battaglia
  • Elena Bozzi


Recent technological advances have given rise to a wide range of diagnostic and interventional imaging-guided procedures for an increasing number of abdominal parenchymal diseases, such as those involving the kidneys, adrenals, or pancreas. However, the liver, and the cirrhotic liver in particular, still represents the main field of application of abdominal imaging modalities. Imaging plays a key role in the diagnostic work-up of the nodular lesion, especially in its initial detection and characterization. In addition, the results of imaging assessment guide the therapeutic options (surgical, interventional, or palliative) and provide the standard of reference in the evaluation of tumor response.


Cirrhotic Liver Nodular Lesion Hepatobiliary Phase Dysplastic Nodule Baseline Magnetic Resonance Imaging 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    International Consensus Group for Hepatocellular Neoplasia. The International Consensus Group for Hepatocellular Neoplasia (2009) Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia. Hepatology 49:658–664CrossRefGoogle Scholar
  2. 2.
    Cosgrove D (2006) Ultrasound contrast agents. An overview. Eur J Radiol 60:324–330CrossRefPubMedGoogle Scholar
  3. 3.
    Bruix J, Sherman M (2005) Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology 42:1208–1236CrossRefPubMedGoogle Scholar
  4. 4.
    Roncalli M, Roz E, Coggi G et al (1999) The vascular profile of regenerative and dysplastic nodules of the cirrhotic liver: implications for diagnosis and classification. Hepatology 30:1174–1178CrossRefPubMedGoogle Scholar
  5. 5.
    Theise, Park YN, Kojiro M (2002) Dysplastic nodules and hepatocarcinogenesis. Clin Liver Dis 6:497–512CrossRefPubMedGoogle Scholar
  6. 6.
    Bartolozzi C, Cioni D, Donati F et al (2001) Focal liver lesions: MR imaging-pathologic correlation. Eur Radiol 11:1374–1388CrossRefPubMedGoogle Scholar
  7. 7.
    Shinmura R, Matsui O, Kobayashi S et al (2006) Cirrhotic nodules: association between MR imaging signal intensity and intranodular blood supply. Radiology 237:512–519CrossRefGoogle Scholar
  8. 8.
    Bartolozzi C, Crocetti L, Lencioni R et al (2007) Biliary and reticuloendhotelial impairment in hepatocarcinogenesis: the diagnostic role of tissue specific MR contrast media. Eur Radiol 17:2519–2530CrossRefPubMedGoogle Scholar
  9. 9.
    Chen RC, Lii JM, Chou CT et al (2008) T2-weighted and T1-weighted dynamic superparamagnetic iron oxide (ferucarbotran) enhanced MRI of hepatocellular carcinoma and hyperplastic nodules. J Formos Med Assoc 107:798–805CrossRefPubMedGoogle Scholar
  10. 10.
    Cioni D, Lencioni R, Bartolozzi C. (2001) Percutaneous ablation of liver malignancies: imaging evaluation of treatment response. Eur J Ultrasound 13:73–93CrossRefPubMedGoogle Scholar

Copyright information

© Springer Verlag Italia 2010

Authors and Affiliations

  • Carlo Bartolozzi
    • 1
  • Valentina Battaglia
    • 1
  • Elena Bozzi
    • 1
  1. 1.Division of Diagnostic and Interventional RadiologyUniversity of PisaPisaItaly

Personalised recommendations